Volume 6 Supplement 3

AIDS Vaccine 2009

Meeting abstracts

Edited by Anna Laura Ross

AIDS Vaccine 2009. Go to conference site.

Paris, France19-22 October 2009

Concatenated PDF 6S3

Page 6 of 10

P14-11. Educating community medical providers about HIV vaccine induced seropositivity

Authors: KE Mark, J Maenza, D Garcia, K Louis, SB Alexander, E Moore, GB Broder, S Wakefield and M McElrath

Citation: Retrovirology 2009 6(Suppl 3):P199

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P14-12. Safety and tolerability of VRC DNA and rAd5 HIV-1 vaccine delivery by intramuscular, subcutaneous and intradermal administration in healthy adults

Authors: ME Enama, L Novik, L Holman, I Gordon, M Nason, J Ledgerwood and BS Graham

Citation: Retrovirology 2009 6(Suppl 3):P200

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P14-13. Long-term follow-up of study participants in HIV prophylactic vaccine clinical trials in Africa

Authors: C Schmidt, W Jaoko, P Kaleebu, E Karita, Lehrman, S Allen, L Dally, C Smith and PE Fast

Citation: Retrovirology 2009 6(Suppl 3):P201

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P15-01. Willingness to participate in actual preventive HIV vaccine phase I/IIa trial in Bangkok, Thailand

Authors: A Hemachandra, RL Puls, SJ Kerr, N Saengthong, K Pussadee, S Emery, P Phanuphak and K Ruxrungtham

Citation: Retrovirology 2009 6(Suppl 3):P202

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P15-02. Participation in immune-based therapy trial excludes participation in future trials: solving this problem

Authors: J Routy, B Lebouche and N Gilmore

Citation: Retrovirology 2009 6(Suppl 3):P203

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P15-03. HIV vaccine funding trends entering a global recession: research and development (R&D) from 2000 – 2008

Authors: K Fisher, C Feuer, P Harrison, W Lee, L Romero, S Vuthoori and M Warren

Citation: Retrovirology 2009 6(Suppl 3):P204

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P15-04. Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells

Authors: CA Todd, X Yu, DA Ozaki, KM Greene, H Gao, B Wood, M Wang, P Gilbert, DC Montefiori and M Sarzotti-Kelsoe

Citation: Retrovirology 2009 6(Suppl 3):P205

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P15-05. Evaluation and recommendations on good clinical laboratory practice (GCLP) guidelines for phase I-III HIV vaccine clinical trials

Authors: M Sarzotti-Kelsoe, J Cox, N Cleland, T Denny, J Hural, L Needham, D Ozaki, IR Rodriguez-Chavez, G Stevens, T Stiles, T Tarragona-Fiol and A Simkins

Citation: Retrovirology 2009 6(Suppl 3):P206

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P15-06. Brighton collaboration viral vector vaccines safety working group (V3SWG): maximizing the comparability and value of safety data from HIV vaccine trials

Authors: RT Chen, J Excler, MP Laderoute, BW Mahy, MP Hendry, CM Via, AA Compingbutra and J Gidudu

Citation: Retrovirology 2009 6(Suppl 3):P207

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P15-07. Knowledge, attitudes, practices and willingness to participate in HIV vaccine trials among urban residents of Bamako, Mali, in West Africa, 2005–2009

Authors: K Tounkara, B Aboubacar, O Koita, A Traore, S Dao, S Moussa, D Ibrahima, S Fanta, F Bougoudogo, R Gerber and AS De Groot

Citation: Retrovirology 2009 6(Suppl 3):P208

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P15-08. Did unblinding affect HIV risk behaviour and risk perception in the HVTN503/Phambili study?

Authors: GE Gray, L Bekker, G Churchyard, M Nchabeleng, K Mlisana, G de Bruyn, S Roux, M Mathebula, M Latka, T Bennie, B Metch, Z Moodie, M Allen, N Eaton and J Kublin

Citation: Retrovirology 2009 6(Suppl 3):P209

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P15-09. The potential global market size and public health value of hypothetical HIV-1 preventive vaccines with different levels of efficacy

Authors: CA Marzetta, SJ Wrobel, KK Singh, ND Russell and J Esparza

Citation: Retrovirology 2009 6(Suppl 3):P210

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P15-10. Preventive HIV vaccine acceptability and behavioral risk compensation among high-risk men who have sex with men and transgenders in Thailand

Authors: PA Newman, S Roungkraphon, S Tepjan and S Yim

Citation: Retrovirology 2009 6(Suppl 3):P211

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P15-11. Preventive HIV vaccine acceptability: a systematic review and meta-analysis

Authors: PA Newman and C Logie

Citation: Retrovirology 2009 6(Suppl 3):P212

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P15-12. Community advisory boards' successes and challenges in AIDS vaccine clinical trials: a Southern Africa experience

Authors: T Mokhele

Citation: Retrovirology 2009 6(Suppl 3):P213

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P15-13. HVTN 503(Phambili) trial discontinuation of enrolment/vaccination: the impact on trial participant attitudes to vaccine trials and scientific research

Authors: D Mark, K Middelkoop, S Roux, G Gray, K Mlisana, M Nchabaleng, G Churchyard, G De Bruyn, M Latka, D Magagula, J Kublin, M Allen and L Bekker

Citation: Retrovirology 2009 6(Suppl 3):P214

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P15-14. Assuring data quality of the phase III vaccine trial of ALVAC vaccine priming and AIDSVAX vaccine boosting in Thailand

Authors: J Kaewkungwal, P Pitisuttithum, S Nitayapan, C Khamboonruang, C Khamboonruang, P Thongchareon, P Kunasol, M Benenson and J Kim

Citation: Retrovirology 2009 6(Suppl 3):P215

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P15-15. Advocates' perspectives on community engagement in the HVTN 505

Authors: M Warren, E Bass, C Feuer, K Fisher, D Grant and L Miller

Citation: Retrovirology 2009 6(Suppl 3):P216

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P15-16. Social factors affecting retention rates in Step study participants in Lima-Peru

Authors: MD Fernandez-Maldonado, P Segura, JR Lama and J Sanchez

Citation: Retrovirology 2009 6(Suppl 3):P217

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P15-17. Social media as a tool for engaging and educating audiences around HIV vaccine research and clinical trial participation

Authors: S Sitar, BI Hartman, BS Graham and JE Ledgerwood

Citation: Retrovirology 2009 6(Suppl 3):P218

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P15-18. Behavioral and social science in HIV vaccine clinical research: workshop recommendations

Authors: C Lau, EM Swann, P Gaist and MA Allen

Citation: Retrovirology 2009 6(Suppl 3):P219

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P15-19. Evaluating community engagement efforts in a large, multi-site, global HIV vaccine trials network

Authors: K Maggard, G Broder, E Maclachlan and A None

Citation: Retrovirology 2009 6(Suppl 3):P220

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P15-20. Developing a national policy agenda for the Canadian HIV vaccine initiative

Authors: V Sarazin, L Jonsdottir, S Sternthal, K Roblin and S Grundy

Citation: Retrovirology 2009 6(Suppl 3):P221

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P15-21. Investigating the utility and relevance of the good participatory practice guidelines for biomedical HIV prevention trials

Authors: L Miller, E Bass, M Warren, K Fisher, D Grant and C Feuer

Citation: Retrovirology 2009 6(Suppl 3):P222

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P15-22. Potential synergies between HIV vaccines, microbicides and pre-exposure prophylaxis

Authors: V Sarazin and P Milsom

Citation: Retrovirology 2009 6(Suppl 3):P223

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P15-23. Community engagement strategies in the Canadian HIV vaccine initiative

Authors: P Milsom, C Cryan, S Sternthal and C Harmston

Citation: Retrovirology 2009 6(Suppl 3):P224

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P15-24. Good participatory practice guidelines begin to take root

Authors: L Miller, E Bass, M Warren, D Grant, A Costelloe-Kuehn, C Feuer and K Fisher

Citation: Retrovirology 2009 6(Suppl 3):P225

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P15-25. Preparation for HIV vaccine trials in Africa: barriers and facilitators for the establishment of a community advisory board in Burkina Faso

Authors: A Berthe, N Meda, IT Traoré, J Some, S Salouka, L Sanou, F Some, J Rouamba, D Ouedraogo, G M'Boutiki, P Mayaud, N Nagot and P Van de perre

Citation: Retrovirology 2009 6(Suppl 3):P226

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P15-26. Leveraging motivators to participation in HIV vaccine research in the age of Obama

Authors: SB Alexander and S Im

Citation: Retrovirology 2009 6(Suppl 3):P227

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P15-27. Community involvement and ethics in HIV vaccine trial in Nigeria

Authors: AO Adeyemi, O Fakunle, OA Adesola and O Olaogun

Citation: Retrovirology 2009 6(Suppl 3):P228

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P15-28. Attitudes and awareness of HIV vaccine research in HIV uninfected MSM in four US cities: Rochester, Boston, San Francisco and Philadelphia

Authors: SB Alexander, CA Bunce, M Lanier, J Maynard and G Morrow-Hall

Citation: Retrovirology 2009 6(Suppl 3):P229

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P16-01. Regulatory T-cells and high levels of FOXP3 mRNA leads to decreased immune responses in HIV-TB co-infection

Authors: A Loxton, T Roberts, G Black and G Walzl

Citation: Retrovirology 2009 6(Suppl 3):P230

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P16-02. Induction of systemic HIV-1 specific cellular immune responses by oral exposure in exposed uninfected partner of discordant couples

Authors: C Pérez, K Hasselrot, K Broliden and A Karlsson

Citation: Retrovirology 2009 6(Suppl 3):P231

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P16-03. Persistence of robust cross-reactive group M consensus T-cell responses in a chronic HIV-1 clade A1 and D-infected Ugandan population

Authors: JJ Serwanga, S Mugaba, EE Pimego, FF Lyagoba, BB Nanteza, EM Katongole, NN Ndembi and PP Kaleebu

Citation: Retrovirology 2009 6(Suppl 3):P232

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P16-04. Cryptic CTL epitopes derived from antisense transcription are frequently recognized in HIV-1 infection

Authors: A Bansal, J Carlson, P Matthews, O Akinsiku, J Yan, S Sabbaj, S Heath, P Goulder, D Heckerman and P Goepfert

Citation: Retrovirology 2009 6(Suppl 3):P233

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P16-05. Upregulation of PD-1 and CTLA-4 on HIV-specific T cells in HIV-infected infants

Authors: BS Nqoko, C Day, N Mansoor, M de Kock, J Hughes, G Hussey and W Hanekom

Citation: Retrovirology 2009 6(Suppl 3):P234

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P16-06. Control of HIV-1 by HIV-1 Pol-specific CD8+ T cells in chronically HIV-1-infected Japanese cohort

Authors: H Murakoshi, H Gatanaga, M Koyanagi, S Oka and M Takiguchi

Citation: Retrovirology 2009 6(Suppl 3):P235

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P16-07. HLA-B1302 is associated with viral control in clade CRF01_AE HIV-1 infection in Thailand

Authors: U Hempel, S Buranapraditkun, P Chatkulkawin, P Pitakpolrat, LC Phillips, RL Allgaier, S Lorenzen, WH Hildebrand, T Leitner, P Matthews, P Goulder, BD Walker, K Ruxrungtham and TM Allen

Citation: Retrovirology 2009 6(Suppl 3):P236

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P16-08. Combined blockade of the PD-1 and IL-10 pathways synergistically enhance HIV-specific CD4 T cell functions

Authors: F Porichis, DS Kwon, DP Tighe, DF Pavlik, DG Kavanagh, GJ Freeman, BD Walker and DE Kaufmann

Citation: Retrovirology 2009 6(Suppl 3):P237

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P16-09. Adenovirus 5 vector HIV vaccination does not affect mucosal homing markers on Ad5-specific CD4+ T-cells in humans

Authors: N Hutnick, D Carnathan, S Dubey, K Cox, S Ratcliffe, MN Robertson, DR Casimiro, HC Ertl and MR Betts

Citation: Retrovirology 2009 6(Suppl 3):P238

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P16-10. IL-2 therapy mediates expansion of Treg cells, maintains IL-17 expressing CD4+ T-cells and selectively suppresses HIV specific T-cell responses

Authors: L Ndhlovu, E Sinclair, L Epling, QX Tan, T Ho, AR Jha, JA Levy, DF Nixon, JD Barbour and FM Hecht

Citation: Retrovirology 2009 6(Suppl 3):P239

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P16-11. HLA-B57/5801 induces preferential CD27 expression on HIV-Gag but not Nef specific central memory CD8+T cells controlling HIV

Authors: J Xie, W Lu, A Samri, D Costagliola, A Schnuriger, BC da Silva, C Blanc, M Almeida, O Pellé, I Theodorou, C Rouzioux and B Autran

Citation: Retrovirology 2009 6(Suppl 3):P240

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P16-12. Relative dominance of Gag-specific cytotoxic T lymphocytes is associated with viral load inversely in HIV-1 clade B' infected Chinese

Authors: M Jia, J Chen, K Hong, S Liu, X Zhang, H Zhao, M Altfeld, B Walker, X Yu and Y Shao

Citation: Retrovirology 2009 6(Suppl 3):P241

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P16-13. A greater breadth of HIV-1-specific T cell responses detected using mosaic peptides compare to consensus peptides

Authors: H Yang, H Yan, W Li, X Zhang, W Fischer, H Zhang, H Wu, BT Korber, AJ McMichael, X Xu and N Goonetilleke

Citation: Retrovirology 2009 6(Suppl 3):P242

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P16-14. Loss of balance between CD4+ regulatory T cell and Th17 population in chronic HIV infection

Authors: D Li, J Chen, M Jia, K Hong, S Liu, X Zhang, H Zhao, H Peng, Q Zhao, P Ma, C Wu and Y Shao

Citation: Retrovirology 2009 6(Suppl 3):P243

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P16-15. Epitope mapping of HIV-specific CD8+ T-cells responses by polyfunctional and proliferation responses reveal distinct specificity defined by function

Authors: ME Richmond, LR McKinnon, S Koesters Kiazyk, C Wachihi, M Kimani, J Kimani, FA Plummer and TB Ball

Citation: Retrovirology 2009 6(Suppl 3):P244

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P16-16. Gag and Nef specific T-cell responses in HIV-1 infected long-term non-progressors in Uganda

Authors: J Kyosiimire-Lugemwa, P Pala, G Miiro, J Todd, P Kaleebu, N Imami and F Gotch

Citation: Retrovirology 2009 6(Suppl 3):P245

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P16-17. Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV suppressive activity

Authors: J Almeida, D Sauce, D Price, L Papagno, S Shin, A Moris, M Larsen, G Pancino, D Douek, B Autran, A Saez-Cirion and V Appay

Citation: Retrovirology 2009 6(Suppl 3):P246

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P16-18. Regulatory T cell frequencies correlate with T cell activation in chronic HIV-1 infection

Authors: M Angin, H Streeck, F Wen, A Pyo, A Trocha, I Toth, D Kwon, F Pereyra, G Alter, M Altfeld, BD Walker and MM Addo

Citation: Retrovirology 2009 6(Suppl 3):P247

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P16-19. Statistical design and analysis of the CAVD-VIMC Elispot transfer study 001

Authors: Y Huang, A Sato, B Wood, D Gill, N Kochar, T Tarragona, A Sambor, H Wan, G Levine, S Self, R Koup, J Cox, R Bailer and J Gilmour

Citation: Retrovirology 2009 6(Suppl 3):P248

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF

AIDS Vaccine 2009

Meeting abstracts

Follow

Annual Journal Metrics

Retrovirology

Contact us